IRulya Therapeutics Inc. Common Stock (IRLA) Stock
NYSE · IRLA
Key stats
- Market cap
- $415.55M
- Price / Earnings ratio
- -0.4x
- EPS (TTM)
- -$142.31
- Volume
- Loading
- 52-week high
- $41.00
- 52-week low
- $0.08
Source: third-party data provider, as of November 13, 2026
Compare with IRLA
Recent news
No recent news
Analyst ratings
No analyst data available
Financials
Performance
Revenue
Net income
Net margin %
2021
2022
2023
2024
2025
0000
Debt & Balance Sheet
Total assets
Total liabilities
2021
2022
2023
2024
2025
201M133M66M0
Revenue to Profit
2025$0.0
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$-84.0M
Net incomeEarnings
No data available
Source: third-party data provider
Fundamentals
Valuation
Price-to-book value-1.11
Profitability
Return on Equity681.00%
Return on Assets-105.00%
EBITDA$-94.49M
Trading
Average volume92,704
Source: third-party data provider, as of November 13, 2026
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.7 | +14.2 |
Compare stocks
Market cap
$415.55M
-
-
-
Price / Earnings ratio
-0.40
-
-
-
Price / Sales ratio
-
-
-
Dividend yield
0.00%
-
-
-
Average volume
92,704
-
-
-
Earnings per share
$-142.31
-
-
-



